These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 26315753)
1. Late Structural Discontinuity as a Possible Cause of Very Late Everolimus-Eluting Bioresorbable Scaffold Thrombosis. Ielasi A; Cortese B; Steffenino G JACC Cardiovasc Interv; 2015 Aug; 8(10):e171-e172. PubMed ID: 26315753 [No Abstract] [Full Text] [Related]
2. First serial assessment at 6 months and 2 years of the second generation of absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study. Ormiston JA; Serruys PW; Onuma Y; van Geuns RJ; de Bruyne B; Dudek D; Thuesen L; Smits PC; Chevalier B; McClean D; Koolen J; Windecker S; Whitbourn R; Meredith I; Dorange C; Veldhof S; Hebert KM; Rapoza R; Garcia-Garcia HM Circ Cardiovasc Interv; 2012 Oct; 5(5):620-32. PubMed ID: 23048057 [TBL] [Abstract][Full Text] [Related]
4. Incidence and imaging outcomes of acute scaffold disruption and late structural discontinuity after implantation of the absorb Everolimus-Eluting fully bioresorbable vascular scaffold: optical coherence tomography assessment in the ABSORB cohort B Trial (A Clinical Evaluation of the Bioabsorbable Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions). Onuma Y; Serruys PW; Muramatsu T; Nakatani S; van Geuns RJ; de Bruyne B; Dudek D; Christiansen E; Smits PC; Chevalier B; McClean D; Koolen J; Windecker S; Whitbourn R; Meredith I; Garcia-Garcia HM; Veldhof S; Rapoza R; Ormiston JA JACC Cardiovasc Interv; 2014 Dec; 7(12):1400-11. PubMed ID: 25523532 [TBL] [Abstract][Full Text] [Related]
5. Bioresorbable vascular scaffold fracture in the overlapping zone as cause of accelerated neoatherosclerosis and in-scaffold very-late thrombosis. Mangiameli A; Fajadet J; Dumonteil N Int J Cardiovasc Imaging; 2017 Jan; 33(1):1-3. PubMed ID: 27562758 [No Abstract] [Full Text] [Related]
6. Very late bioresorbable vascular scaffold thrombosis due to late device recoil. Cortese B; Piraino D; Ielasi A; Steffenino G; Orrego PS Int J Cardiol; 2015; 189():132-3. PubMed ID: 25889443 [No Abstract] [Full Text] [Related]
7. Bioresorbable vascular scaffold versus everolimus-eluting stents or drug eluting balloon for the treatment of coronary in-stent restenosis: 1-Year follow-up of a propensity score matching comparison (the BIORESOLVE-ISR Study). Moscarella E; Tanaka A; Ielasi A; Cortese B; Coscarelli S; De Angelis MC; Piraino D; Latib A; Grigis G; Bianchi R; Buccheri D; Calabrò P; Tespili M; Silva Orrego P; Colombo A; Varricchio A Catheter Cardiovasc Interv; 2018 Oct; 92(4):668-677. PubMed ID: 29356269 [TBL] [Abstract][Full Text] [Related]
8. Everolimus-eluting bioresorbable scaffold implantation for the treatment of bifurcation lesions - Implications from early clinical experience during daily practice. Wiebe J; Dörr O; Bauer T; Liebetrau C; Boeder N; Möllmann H; Hamm CW; Nef HM Cardiovasc Revasc Med; 2016; 17(5):313-7. PubMed ID: 27085220 [TBL] [Abstract][Full Text] [Related]
16. Effect of Post-Dilatation Following Primary PCI With Everolimus-Eluting Bioresorbable Scaffold Versus Everolimus-Eluting Metallic Stent Implantation: An Angiographic and Optical Coherence Tomography TROFI II Substudy. Yamaji K; Brugaletta S; Sabaté M; Iñiguez A; Jensen LO; Cequier A; Hofma SH; Christiansen EH; Suttorp M; van Es GA; Sotomi Y; Onuma Y; Serruys PW; Windecker S; Räber L JACC Cardiovasc Interv; 2017 Sep; 10(18):1867-1877. PubMed ID: 28935079 [TBL] [Abstract][Full Text] [Related]
17. Randomized comparison of everolimus-eluting stents and sirolimus-eluting stents in patients with ST elevation myocardial infarction: RACES-MI trial. Di Lorenzo E; Sauro R; Varricchio A; Capasso M; Lanzillo T; Manganelli F; Carbone G; Lanni F; Pagliuca MR; Stanco G; Rosato G; Suryapranata H; De Luca G JACC Cardiovasc Interv; 2014 Aug; 7(8):849-56. PubMed ID: 25147029 [TBL] [Abstract][Full Text] [Related]
18. First in human: imaging guided bioresorbable magnesium scaffolds in acute myocardial infarction. Alfonso F; García-Guimaraes M; Bastante T; González-Bartol E; Cuesta J; Rivero F Coron Artery Dis; 2018 Aug; 29(5):441-443. PubMed ID: 29537986 [No Abstract] [Full Text] [Related]
19. Clinical results of bioresorbable drug-eluting scaffolds in short and long coronary artery lesions using the PSP technique. Reichart C; Wöhrle J; Markovic S; Rottbauer W; Seeger J BMC Cardiovasc Disord; 2019 Jan; 19(1):22. PubMed ID: 30658574 [TBL] [Abstract][Full Text] [Related]
20. A prospective evaluation of a standardized strategy for the use of a polymeric everolimus-eluting bioresorbable scaffold in ST-segment elevation myocardial infarction: Rationale and design of the BVS STEMI STRATEGY-IT study. Ielasi A; Varricchio A; Campo G; Leoncini M; Cortese B; Vicinelli P; Brugaletta S; di Uccio FS; Latib A; Tespili M Catheter Cardiovasc Interv; 2017 Jun; 89(7):1129-1138. PubMed ID: 27774758 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]